| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenues | $32.5M+14946.3% | $216K-99.6% | $57.4M-99.9% | $51.35B+92731.4% | $55.3M-23.0% | $71.9M-2.1% | $73.4M+21.6% | $60.4M+292.4% | $15.4M |
| Research and development | $37.4M-0.6% | $37.6M-7.3% | $40.6M-99.9% | $63.39B+32634.2% | $193.7M-25.8% | $261.0M+19.0% | $219.2M+8.9% | $201.3M+15.8% | $173.9M |
| Selling, general and administrative | $73.7M+6.5% | $69.2M-1.3% | $70.1M-99.9% | $67.07B+67448.5% | $99.3M-8.5% | $108.5M+2.3% | $106.1M+9.3% | $97.1M+1.5% | $95.6M |
| Impairment of long-lived assets (non-cash) | $0-100.0% | $4.5M | — | — | — | — | — | — | — |
| Total expenses | $111.1M-0.2% | $111.3M-1.9% | $113.5M-99.9% | $143.30B+45669.8% | $313.1M-15.3% | $369.5M+13.6% | $325.3M+8.8% | $299.1M+8.6% | $275.5M |
| Loss from operations | -$3.6M+92.3% | -$46.9M+16.2% | -$56.0M+99.9% | -$91.96B-35572.1% | -$257.8M+13.4% | -$297.6M-18.1% | -$251.9M-5.5% | -$238.8M+8.2% | -$260.1M |
| Net gain on realized contingent milestone and royalty assets | $75.1M | — | — | — | — | — | — | — | — |
| TRELEGY milestone income | $50.0M | — | — | — | — | — | — | — | — |
| Interest expense (non-cash) | -$2.5M+3.3% | -$2.5M-8.3% | -$2.4M | — | — | — | — | — | — |
| Interest and other income, net | $10.2M+108.4% | $4.9M-46.5% | $9.1M-99.9% | $8.54B+770414.0% | $1.1M-60.8% | $2.8M-66.3% | $8.4M-29.8% | $12.0M+149.9% | $4.8M |
| Income (loss) before income taxes | $129.2M+389.7% | -$44.6M+9.4% | -$49.3M+99.9% | -$92.81B-34895.2% | -$265.2M+12.6% | -$303.3M-25.5% | -$241.7M-6.9% | -$226.1M+16.8% | -$271.7M |
| Provision for income tax benefit (expense) | -$23.4M-97.8% | -$11.8M-99.3% | -$5.9M+34.2% | -$9.0M-6060.3% | $151K-98.2% | $8.5M+63.2% | $5.2M-50.6% | $10.6M+177.1% | -$13.7M |
| Net income (loss) | $105.9M+287.7% | -$56.4M-2.2% | -$55.2M-100.0% | $872.13B+437421.1% | -$199.4M+28.3% | -$278.0M-17.6% | -$236.5M-9.7% | -$215.5M+24.5% | -$285.4M |
| Net income (loss) per share - basic (in dollars per share) | $2100.00+282.6% | -$1150.00-15.0% | -$1000.00-108.4% | $11850.00+512.9% | -$2870.00+35.7% | -$4460.00-4.9% | -$4250.00 | — | — |
| Net income (loss) per share - diluted (in dollars per share) | $2060.00+279.1% | -$1150.00-15.0% | -$1000.00-108.4% | $11850.00+512.9% | -$2870.00+35.7% | -$4460.00-4.9% | -$4250.00 | — | — |
| Shares used to compute net income (loss) per share - basic (in shares) | $50317000.00+3.0% | $48847000.00-11.7% | $55303000.00-24.9% | $73591000.00+5.9% | $69461000.00+11.4% | $62345000.00+12.1% | $55610000.00 | — | — |
| Shares used to compute net income (loss) per share - diluted (in shares) | $51507000.00+5.4% | $48847000.00-11.7% | $55303000.00-24.9% | $73591000.00+5.9% | $69461000.00+11.4% | $62345000.00+12.1% | $55610000.00 | — | — |
| Collaboration Agreement | |||||||||
| Licensing and Milestone | |||||||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.